TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Alfimed AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
21,197
|
18,135
|
19,464 |
Financial expenses |
875
|
5
|
1 |
Earnings before taxes |
3,477
|
4,574
|
7,252 |
Total assets |
9,774
|
9,731
|
11,081 |
Current assets |
9,566
|
9,507
|
10,942 |
Current liabilities |
6,633
|
6,076
|
8,245 |
Equity capital |
3,141
|
3,655
|
2,836 |
- share capital |
100
![]() |
100
![]() |
100 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.1%
|
37.6%
|
25.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
16.4%
|
25.2%
|
37.3% |
Return on assets (ROA) |
44.5%
|
47.1%
|
65.5% |
Current ratio |
144.2%
|
156.5%
|
132.7% |
Return on equity (ROE) |
110.7%
|
125.1%
|
255.7% |
Change turnover |
3,062
|
-1,329
|
5,730 |
Change turnover % |
17%
|
-7%
|
42% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.